Piroxicam as Anti-Angiogenic Cancer Therapy
Uses/Indications: Piroxicam's primary use is in dogs as adjunctive therapy for bladder transitional cell carcinoma. It may also be of benefit in squamous cell carcinoma, mammary adenocarcinoma, and transmissible venereal tumor (TVT). It also offers additional benefit as an NSAID reducing pain and inflammation. Anti-angiogenic therapy which is designed to cut off blood supply to [...]